Prospectively reported symptom change across the menstrual cycle in users and non-users of oral contraceptives

Journal of Psychosomatic Obstetrics and Gynecology

Volumn 24, Issue 1, 2003, Pages 15-29

  Ross, C ^a,b   Coleman, G ^a   Stojanovska, C ^a  

^a MONASH UNIVERSITY   (Australia)

^b Mercer   (Australia)

Author keywords

Oral contraceptives; PMS; Premenstrual symptoms

Indexed keywords

CONTRACEPTIVE AGENT; ORAL CONTRACEPTIVE AGENT;

ABDOMINAL PAIN; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BEHAVIOR; BREAST TENDERNESS; COGNITION; CONTRACEPTION; DISEASE SEVERITY; DISTRESS SYNDROME; DRUG FORMULATION; FEMALE; FLUID RETENTION; HORMONAL CONTRACEPTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MASTALGIA; MENSTRUAL CYCLE; MOOD; ORAL CONTRACEPTION; PREMENSTRUAL SYNDROME; QUESTIONNAIRE; SOMATIZATION; SYMPTOMATOLOGY;

EID: 0037356539     PISSN: 0167482X     EISSN: None     Source Type: Journal    
DOI: 10.3109/01674820309042797     Document Type: Article

References (57)

1. Logue CM, Moos R. Perimenstrual symptoms: Prevalence and risk factors. Psychosom Med 1986;48:388-414
2. Choi PYL. The menstrual cycle and premenstrual syndrome. What is this news on the menstrual cycle and premenstrual syndrome? Soc Sci Med 1995;41:759-60
3. Hamilton JA, Parry BL, Alagna S, et al. Premenstrual mood changes: A guide to evaluation and treatment. Psychiatry Annals 1984;14:426-35
4. Herrera E, Gómez-Amor J, Martínez-Selva JM, et al. Relationship between personality, psychological and somatic symptoms and the menstrual cycle. Pets Indiv Diff 1990;11:457-61
5. Boyle GJ, Grant AF. Prospective versus retrospective assessment of menstrual cycle symptoms and mood: Role of attitudes and beliefs. J Psychopath Behav Assess 1992;14:307-21
6. Woods NF, Most A, Defy GK. Toward a construct of perimenstrual distress. Res Nuts Health 1982;5:123-36
7. Sanders D, Warner P, Backstrom T, et al. Mood, sexuality, hormones and the menstrual cycle. I. Changes in mood and physical state: description of subjects and method. Psychosom Med 1983;45:487-501
8. Van der Ploeg HM, Lodder EB. Longitudinal measurement in the diagnostics of the premenstrual syndrome. J Psychosom Res 1993;37:33-8
9. Englander-Golden P, Whitmore MR, Dienstbier RA. Menstrual cycle as focus of study and self-reports of moods and behavior. Motiv Emo 1978;2:75-86
10. van den Akker O, Steptoe A. The pattern and prevalence of symptoms during the menstrual cycle. Br J Psychiatry 1985;147:164-9
11. Haskett RF. Premenstrual dysphoric disorder: Evaluation, pathophysiology and treatment. Prog Neuropsychopharmacol Biol Psychiatry 1987;11:129-35
12. Blumenthal SJ, Nadelson CC. Late luteal phase dysphoric disorder (premenstrual syndromes): Clinical implications. J Clin Psychiatry 1988;49:469-74
13. Coleman GJ, Hart WG, Russell JW. Temporal sequence of symptoms in women complaining of PMS. J Psychosom Obstet Gynecol 1988;8:105-12
14. Metcalf MG, Livesey JH, Wells JE, et al. Physical symptom cyclicity in women with and without the premenstrual syndrome. J Psychosom Res 1990;34:203-13
15. Moos RH. The development of a Menstrual Distress Questionnaire. Psychosom Med 1968;30:853-67
16. Moos RH. Menstrual Distress Questionnaire manual. Los Angeles: Western Psychological Services, 1986
17. Clare AW, Wiggins RD. The construction of a modified version of the Menstrual Distress Questionnaire for use in general practice populations. In Carenza L, Zichella L, eds. Emotion and Reproduction. vol 20, London: Academic Press, 1979:191-7
18. Sheldrake P, Cormack M. Variations in menstrual symptom reporting. J Psychosom Res 1976;20:169-77
19. Kessel N, Coppen AJ. The prevalence of common menstrual symptoms. Lancet 1963;ii:61-4
20. High RV, Marcellino PA. Premenstrual symptoms and the female employee. Soc Behav Pers 1995;23:265-72
21. Halbreich U, Endicott J, Schacht S, et al. The diversity of premenstrual changes as reflected in the Premenstrual Assessment Form. Acta Psychiatr Scand 1982;65:46-65
22. Yuk VJ, Jugdutt AV, Cumming CE, et al. Toward a definition of PMS: A factor analytic evaluation of premenstrual change in non-complaining women. J Psychosom Res 1990;34:439-46
23. Sveinsdóttir H, Bäckström T. Prevalence of menstrual cycle symptom cyclicity and premenstrual dysphoric disorder in a random sample of women using and not using oral contracptives. Acta Obstet Gynecol Scand 2000;79:405-13
24. Magos AL, Brincat M, Studd JWW. Treatment of the premenstrual syndrome by subcutaneous oestradiol implants and cyclical oral norethisterone: Placebo controlled study. Br Med J 1986;292:1629-33
25. Youdale JVM, Freeman RJ. Premenstrual assessment form typological categories: Classification of self-defined premenstrually symptomatic and asymptomatic women. J Consult Clin Psychol 1987;55:418-22
26. Kutner SJ, Brown WL. Types of oral contraceptives, depression and premenstrual symptoms. J New Ment Dis 1972;155:153-62
27. Rouse P. Premenstrual tension: A study using the Moos Menstrual Questionnaire. J Psychosom Res 1978;22:215-22
28. Andersch B, Hahn L. Premenstrual complaints. II. Influence of oral contraceptives. Acta Obstet Gynecol Scand 1981;60:579-83
29. Graham CA, Sherwin BB. The relationship between retrospective premenstrual symptom reporting and present oral contraceptive use. J Psychosom Res 1987;31:45-53
30. Dalton K. The premenstrual syndrome and progesterone therapy. London: Heinemann, 1977
31. Woods NF, Most A, Dery GK. Prevalence of perimenstrual symptoms. Am J Public Health 1982;72:1257-64
32. Paige KE. Effects of oral contraceptives on affective-fluctuations associated with the menstrual cycle. Psychosom Med 1971;33:515-36
33. Walker A, Bancroft J. Relationship between premenstrual symptoms and oral contraceptive use: A controlled study. Psychosom Med 1990;52:86-96
34. van den Boogaard TGHM, Bijleveld CCJH. Daily menstrual symptom measures in women and men using an extended version of Moos's instrument. J Psychosom Obstet Gynecol 1988;9:103-10
35. Graham CA, Sherwin BB. A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive. J Psychosom Res 1992;36:257-66
36. Harding CM, Vail C, Brown R. Effect of oral contraceptives and some psychological factors on the menstrual experience. J Biosoc Sci 1985;17:291-304
37. Marriott A, Faragher EB. An assessment of psychological state associated with the menstrual cycle in users of oral contraception. J Psychosom Res 1986;30:41-7
38. Warner P, Bancroft J. Mood, sexuality, oral contraceptives and the menstrual cycle. J Psychosom Res 1988;32:417-27
39. Wilcoxin LA, Schrader SL, Sherif CW. Daily self-reports on activities, life events, moods, and somatic changes during the menstrual cycle. Psychosom Med 1978;38:399-417
40. Australian Bureau of Statistics. Family Characteristics (Cat, no. 4442.0). Canberra: Australian Bureau of Statistics, 1997
41. Australian Bureau of Statistics. Australian Women's Yearbook (Cat. no. 4124.0). Canberra: Australian Bureau of Statistics, 1997
42. Markum RS. Assessment of the reliability of and the effect of neutral instructions on the symptom ratings on the Moos Menstrual Distress Questionnaire. Psychosom Med 1976;38:163-72
43. Hart WG, Coleman GJ, Russell JW. Assessment of premenstrual symptomatology: a reevaluation of the predictive validity of self-report. J Psychosom Res 1987;31:185-90
44. Russell JW, Coleman GJ, Hart WG. Validation of a modified version of the Menstrual Distress Questionnaire: a case for false attribution? J Psychosom Obstet Gynecol 1988;8:19-29
45. Bains GK, Slade P. Attributional patterns, moods, and the menstrual cycle. Psychosom Med 1988;50:469-76
46. Picone L, Kirkby RJ. Relationship between anxiety and premenstrual syndrome. Psychol Rep 1990;67:43-8
47. van den Akker O, Sharifan N, Packer A, et al. Contribution of generalized negative affect to elevated menstrual cycle symptom reporting. Health Care for Women Int 1995;16:263-72
48. Walker A. Mood and well-being in consecutive menstrual cycles. Psychol Women Q 1994;18:271-90
49. Rubinow DR, Roy-Byrne P, Hoban MC, et al. Prospective assessment of menstrually related mood disorders. Am J Psychiatry 1984;141:684-6
50. Gallant SJ, Popiel DA, Hoffman DM, et al. Using daily ratings to confirm premenstrual syndrome/late luteal phase dysphoric disorder. Part II. What makes a 'real' difference? Psychosom Med 1992;54:167-81
51. Christensen AP, Oei TPS. Correlates of premenstrual dysphoria in help-seeking women. J Affect Disord 1995;33:47-55
52. Moos RH, Kopell BS, Melges FT, et al. Fluctuations in symptoms and moods during the menstrual cycle. J Psychosom Res 1969;13:37-44
53. Gallant SJ, Popiel DA, Hoffman DM, et al. Using daily ratings to confirm premenstrual syndrome/late luteal phase dysphoric disorder. Part I. Effects of demand characteristics and expectations. Psychosom Med 1992;54:149-66
54. Slade P. Premenstrual emotional changes in normal women: Fact or fiction. J Psychosom Res 1984;28:1-7
55. Hargrove JT, Abraham GE. The incidence of premenstrual tension in a gynecologic clinic. J Reprod Med 1982;27:721-4
56. Corney RH, Stanton R. A survey of 658 women who report symptoms of premenstrual syndrome. J Psychosom Res 1991;35:471-82
57. Coppen AJ, Milne HB, Outram DH, et al. Dytide, norethisterone and a placebo in the premenstrual syndrome - A double-blind comparison. J Clin Trials 1972;6:33-6